Chargement en cours...

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil

Objective: Switching between second-generation antipsychotics (SGAs) is a common clinical practice in the treatment of schizophrenia and schizoaffective disorders due to differences in the drugs’ tolerability and safety profiles as well as the challenge of obtaining an ideal response. However, the f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Fulone, Izabela, Silva, Marcus Tolentino, Lopes, Luciane Cruz
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8201606/
https://ncbi.nlm.nih.gov/pubmed/34135752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.638001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!